Tag: mitral regurgitation
Health Canada grants approval for use of Pascal Precision to reduce significant, symptomatic MR
Edwards Lifesciences has announced Health Canada’s approval of the company's Pascal Precision transc...
CUTTING-EDGE registry data sheds light on surgical outcomes following failed transcatheter edge-to-edge repair
Gilbert Tang (New York, USA) talks to Cardiovascular News about the key findings from the CUTTIN...
A higher volume of mitral valve repair procedures is associated with lower mortality rates
US national hospital- and surgeon-level inverse volume–outcome associations were observed for 30...
Approval of Tendyne TMVI device means physicians now have a portfolio of options for treating mitral regurgitation
Abbott made history in January when it became the first company in the world to receive market a...
Cardiovalve receives Breakthrough Device Designation for its transcatheter tricuspid valve replacement system
Cardiovalve has received US Food and Drug Administration (FDA) approval for an early feasibility...
“Our goal is to treat more patients with mitral regurgitation”
Last month, Abbott announced US Food and Drug Administration (FDA) approval of a new trial—REPAI...
Abbott gets green light for trial on MitraClip in moderate surgical risk patients
Abbott has announced that the US Food and Drug Administration (FDA) has approved a first-of-its-...
PCR London Valves 2019: One-year survival better with Mitra Clip than with medical therapy among COAPT-excluded patients
A single-centre real world experience has found that the vast majority of patients with severe mitra...
Carillon Mitral Contour System reaches 1,000 implants for functional mitral regurgitation
Cardiac Dimensions has announced in a press release that its Carillon Mitral Contour S...
PASCAL poised to rival MitraClip for safety and efficacy
PASCAL’s (Edwards Lifesciences) safety and efficacy may rival that of MitraClip (Abbott) for the...
Boston Scientific exercises option to acquire Millipede
Boston Scientific has exercised its option to acquire the remaining shares of Millipede, upon it...
ESC 2018: MitraClip makes “absolutely no difference” for the prognosis of secondary mitral valve regurgitation
The first randomised controlled trial to compare percutaneous edge-to-edge repair (MitraClip, Ab...
Controlling blood pressure may help to prevent mitral regurgitation
A new study indicates that long-term exposure to elevated blood pressure is associated with an i...
Neovasc provides Tiara clinical update
Neovasc has provided an update on the study progress and clinical performance of the Tiara valve...
4C Medical receives over US$8 million financing for transcatheter mitral regurgitation treatment
4C Medical has received approximately US$9 million in unsecured convertible promissory notes. The co...
Second successful annuloplasty performed using Micro Interventional Devices minimally invasive technology
The second clinical case using Micro Interventional Devices’ proprietary MIA (minimally invasive ann...
Patient with tricuspid regurgitation successfully treated with world’s first transcatheter tricuspid valved stent
NaviGate Cardiac Structures has announced that a novel valved stent that can capture the enlarged an...
FDA grant Cardiac Dimensions investigational device exemption approval to conduct study
Cardiac Dimensions has received FDA approval for its investigational device exemption (IDE) CARILLON...
